Jiutian Chemical FY2025 net loss deepens 13% to RMB167m despite 113% revenue jump to RMB107m; cash plunges 64% and no dividend
Summary:
-
Full-year revenue more than doubled to RMB107.5 million from RMB50.6 million, driven by trial production and sales from the new 100,000‑ton methylamine plant and expanded chemical trading, but prices remained below cost.
-
Gross loss widened to RMB107.5 million (FY2024: RMB83.2 million) as continued overcapacity and weak China demand kept selling prices under production cost, though gross loss margin improved on operational efficiencies.
-
Net loss attributable to shareholders increased to RMB166.97 million from RMB147.90 million, weighed by RMB11.38 million impairment on property, plant and equipment, RMB4.27 million impairment on financial assets and ongoing associate losses, partly offset by lower admin and distribution expenses.
-
Cash and cash equivalents dropped to RMB198.0 million from RMB515.9 million, with operating cash outflow of RMB124.0 million and total bank borrowings reduced to RMB125.4 million from RMB284.0 million; net asset value per share fell to 22.68 RMB cents from 31.08 cents.
-
The board proposed no dividend for FY2025, citing the need to conserve resources amid a still‑weak chemical market marked by soft demand, oversupply, pricing pressure and macro/geopolitical uncertainties in the next 12 months.